ArticleNeoplasia (New York, N.Y.)2022

Inhibition of DNA-PK may improve response to neoadjuvant chemoradiotherapy in rectal cancer.

Mary Smithson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.